Anatara Lifesciences Ltd (ANR:ASX)

19.5¢

right-arrow Created with Sketch. 0.005 (2.63%)
MCAP $13.38M
Last trade 09.59am 22/01/2021 20mins delayed

Latest Announcements

09.26am 22/01/2021ANRAnatara Lifesciences Ltd
14/12/2020ANRAnatara Lifesciences Ltd
08/12/2020ANRAnatara Lifesciences Ltd
04/12/2020ANRAnatara Lifesciences Ltd
04/12/2020ANRAnatara Lifesciences Ltd
04/12/2020ANRAnatara Lifesciences Ltd
80
MCap
04/12/2020ANRAnatara Lifesciences Ltd
63
MCap
04/12/2020ANRAnatara Lifesciences Ltd
92
MCap

Company Overview

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.

ANR in the news

Search Previous Announcements